You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BL

Showing 1 - 25 of 4,538
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Small Cell Lung Cancer Trial in Changchun (BL-B01D1, SI-B003)

Not yet recruiting
  • Small Cell Lung Cancer
  • Changchun, Jilin, China
    Jilin Cancer Hospital
Jun 21, 2023

Cervical Cancer Trial in Beijing (BL-B01D1, SI-B003)

Not yet recruiting
  • Cervical Cancer
  • Beijing, Beijing, China
    Cancer Hospital Chinese Academy of Medical Sciences
Aug 16, 2023

Head and Neck Squamous Cell Carcinoma Trial in Shanghai (BL-B01D1, SI-B003)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Aug 17, 2023

Healthy Subjects Trial in Phoenix (1.25 mg/kg BL-8040 + BL-8040-matching , 2 mg/kg BL-8040, BL-8040-matching )

Completed
  • Healthy Subjects
  • 1.25 mg/kg BL-8040 + BL-8040-matching placebo
  • +3 more
  • Phoenix, Arizona
    Celerion
Jan 1, 2023

Gynecological Malignancies Trial in Beijing (BL-M07D1)

Not yet recruiting
  • Gynecological Malignancies
  • Beijing, Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences
Nov 15, 2023

Surgical Operation, Edentulous Jaw, Edentulous Mouth Trial (Axiom BL X3)

Not yet recruiting
  • Surgical Operation
  • +3 more
  • Axiom BL X3
  • (no location specified)
Mar 2, 2023

Healthy Volunteers Trial in Arzo (BL-001, Placebo)

Recruiting
  • Healthy Volunteers
  • Arzo, Canton Ticino, Switzerland
    CROSS Research S.A.
Apr 17, 2023

Her2-positive/Low-expression Urinary and Digestive Tract Tumors Trial in Beijing (BL-M07D1)

Not yet recruiting
  • Her2-positive/Low-expression Urinary and Digestive Tract Tumors
  • Beijing, Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences
Sep 8, 2023

Locally Advanced or Recurrent Metastatic HER-2 Negative Breast Cancer Trial in Shanghai (BL-B01D1, SI-B003)

Not yet recruiting
  • Locally Advanced or Recurrent Metastatic HER-2 Negative Breast Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Sep 12, 2023

NSCLC Trial in Shanghai (BL-M02D1)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Shanghai, Shanghai, China
    Shanghai Pulmonary Hospital
Jul 10, 2023

NSCLC Trial in Guangzhou (BL-M07D1)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Nov 1, 2023

Non Small Cell Lung Cancer, NSCLC, Lung Cancer Trial in Port Saint Lucie, Greenville (BL-B01D1)

Recruiting
  • Non Small Cell Lung Cancer
  • +2 more
  • Port Saint Lucie, Florida
  • +1 more
Aug 11, 2023

Urothelial Carcinoma Trial in Shanghai (BL-B01D1, SI-B003)

Not yet recruiting
  • Urothelial Carcinoma
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 27, 2023

Gynecological Malignant Tumor, Solid Tumor Trial in Shanghai (BL-B01D1)

Not yet recruiting
  • Gynecological Malignant Tumor
  • Solid Tumor
  • Shanghai, Shanghai, China
    Fudan University ShangHai Cancer Center
Apr 9, 2023

NSCLC Trial in Shanghai (BL-B01D1, Osimertinib Mesylate Tablets)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Shanghai, Shanghai, China
    Shanghai Pulmonary Hospital
May 25, 2023

Urinary System Tumor, Solid Tumor Trial in Shanghai (BL-B01D1)

Not yet recruiting
  • Urinary System Tumor
  • Solid Tumor
  • Shanghai, Shanghai, China
    Fudan University ShangHai Cancer Center
Mar 26, 2023

Nasopharyngeal Carcinoma Trial in Guangzhou (BL-B01D1, capecitabine, gemcitabine)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Oct 31, 2023

Esophageal Cancer, Gastric Cancer, Colorectal Cancer Trial in Beijing (SI-B003, BL-B01D1)

Not yet recruiting
  • Esophageal Cancer
  • +2 more
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Aug 22, 2023

Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) Trial in China (BL-M11D1)

Not yet recruiting
  • Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)
  • Hefei, Anhui, China
  • +7 more
Jun 27, 2023

Locally Advanced or Metastatic Urinary Tumors, Other Solid Tumors Trial in Beijing (BL-B01D1)

Recruiting
  • Locally Advanced or Metastatic Urinary Tumors
  • Other Solid Tumors
  • Beijing, Beijing, China
  • +3 more
Jan 11, 2023

Locally Advanced or Metastatic Digestive Tract Tumors and Other Solid Tumors Trial in Shanghai (BL-M07D1)

Recruiting
  • Locally Advanced or Metastatic Digestive Tract Tumors and Other Solid Tumors
  • Shanghai, Shanghai, China
    Fudan University ShangHai Cancer Center
Jan 11, 2023

Advanced Solid Tumor Trial in Kuching (BL0020)

Not yet recruiting
  • Advanced Solid Tumor
  • Kuching, Malaysia
    Sarawak General Hospital
May 24, 2023

Gastroenteric Tumor Trial in Guangzhou (BL-M02D1)

Recruiting
  • Gastroenteric Tumor
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Jul 31, 2022

Overweight/Obese Adults Trial (Probiotics)

Not yet recruiting
  • Overweight/Obese Adults
  • Probiotics
  • (no location specified)
Nov 17, 2023

T-Acute Lymphoblastic Leukemia, Adult T Lymphoblastic Lymphoma Trial in United States (BL-8040, Nelarabine)

Terminated
  • T-Acute Lymphoblastic Leukemia
  • Adult T Lymphoblastic Lymphoma
  • Saint Louis, Missouri
  • +1 more
Jan 18, 2023